Company Number: 13148796

Analysis Date: 2025-07-29 17:00 UTC

1. Risk Rating: MEDIUM
   IREMCO LIMITED shows an improving financial position with a turnaround from net liabilities in previous years to net assets in 2024. However, the company is still early in its lifecycle (incorporated in 2021) with relatively low capital and modest financial scale. The presence of director loans and prior losses warrant caution.

2. Key Concerns:

• Historical net liabilities and negative shareholders’ funds in 2021 and 2022, indicating prior insolvency risk.
• Reliance on director advances (loans) totaling approximately £2,650, which may affect financial stability if not converted or repaid.
• Lack of employee base and limited operational scale suggests dependency on directors’ involvement and potential challenges in sustaining growth or operations.

3. Positive Indicators:

• Significant improvement in current assets from zero to nearly £6,000 in cash, leading to positive net current assets and net asset position in the latest year.
• Timely and compliant filing of accounts and confirmation statements with no overdue filings or penalties.
• Directors’ professional backgrounds (a GP and a fundraiser) may provide operational and funding expertise relevant to the company’s activities.

4. Due Diligence Notes:

• Review nature and terms of director advances to assess risks of repayment and their impact on cash flow and solvency.
• Investigate revenue streams, profitability, and business model sustainability given zero employees and limited asset base.
• Confirm regulatory compliance beyond filings, especially given medical practice SIC code, which may involve external licenses or certifications not detailed here.